Global Necrotic Enteritis Treatment Market Growth 2025-2031
Description
The global Necrotic Enteritis Treatment market size is predicted to grow from US$ 29570 million in 2025 to US$ 45030 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.
Necrotic enteritis is an enteric disease of poultry characterized by patches of necrotic tissue on the intestinal epithelium. This disease can cause high mortality, primarily in juvenile broilers.
United States market for Necrotic Enteritis Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Necrotic Enteritis Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Necrotic Enteritis Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Necrotic Enteritis Treatment players cover Prometic Life Sciences Inc., BioGaia Probiotics, Fresenius Kabi AG, Actavis Plc., Bayer International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Necrotic Enteritis Treatment Industry Forecast” looks at past sales and reviews total world Necrotic Enteritis Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Necrotic Enteritis Treatment sales for 2025 through 2031. With Necrotic Enteritis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Necrotic Enteritis Treatment industry.
This Insight Report provides a comprehensive analysis of the global Necrotic Enteritis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Necrotic Enteritis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Necrotic Enteritis Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Necrotic Enteritis Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Necrotic Enteritis Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Necrotic Enteritis Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Oral
Parenteral
Segmentation by Application:
Hospital
Clinic
Home
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Prometic Life Sciences Inc.
BioGaia Probiotics
Fresenius Kabi AG
Actavis Plc.
Bayer International
Alcon Laboratories, Inc.
Bausch & Lomb Incorporated
GlaxoSmithKline plc.
Pfizer
Transo-Pharm
Rochem International
HELM Portugal
Key Questions Addressed in this Report
What is the 10-year outlook for the global Necrotic Enteritis Treatment market?
What factors are driving Necrotic Enteritis Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Necrotic Enteritis Treatment market opportunities vary by end market size?
How does Necrotic Enteritis Treatment break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Necrotic enteritis is an enteric disease of poultry characterized by patches of necrotic tissue on the intestinal epithelium. This disease can cause high mortality, primarily in juvenile broilers.
United States market for Necrotic Enteritis Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Necrotic Enteritis Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Necrotic Enteritis Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Necrotic Enteritis Treatment players cover Prometic Life Sciences Inc., BioGaia Probiotics, Fresenius Kabi AG, Actavis Plc., Bayer International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Necrotic Enteritis Treatment Industry Forecast” looks at past sales and reviews total world Necrotic Enteritis Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Necrotic Enteritis Treatment sales for 2025 through 2031. With Necrotic Enteritis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Necrotic Enteritis Treatment industry.
This Insight Report provides a comprehensive analysis of the global Necrotic Enteritis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Necrotic Enteritis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Necrotic Enteritis Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Necrotic Enteritis Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Necrotic Enteritis Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Necrotic Enteritis Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Oral
Parenteral
Segmentation by Application:
Hospital
Clinic
Home
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Prometic Life Sciences Inc.
BioGaia Probiotics
Fresenius Kabi AG
Actavis Plc.
Bayer International
Alcon Laboratories, Inc.
Bausch & Lomb Incorporated
GlaxoSmithKline plc.
Pfizer
Transo-Pharm
Rochem International
HELM Portugal
Key Questions Addressed in this Report
What is the 10-year outlook for the global Necrotic Enteritis Treatment market?
What factors are driving Necrotic Enteritis Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Necrotic Enteritis Treatment market opportunities vary by end market size?
How does Necrotic Enteritis Treatment break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
117 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Necrotic Enteritis Treatment by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Necrotic Enteritis Treatment by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
